This grant is designed to enhance the utilization of HIV Pre-exposure Prophylaxis (PrEP), particularly among Men who have Sex with Men (MSM), by addressing multiple aspects of PrEP implementation and choice. It aims to deploy evidence-based educational resources and support tools within clinical settings. The primary objectives include increasing PrEP screening, counseling, initiation, adherence, and persistence among MSM. Furthermore, this initiative seeks to deepen understanding of real-world PrEP use, including factors influencing the selection of various formulations (daily, 2-1-1, injectable) and patterns of switching between them. Implementation science methodologies will be employed to evaluate the effectiveness of these interventions and to collect comprehensive data on PrEP uptake in a landscape of evolving options.
Opportunity ID: 328319
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-21-003 |
| Funding Opportunity Title: | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 93.941 — HIV Demonstration, Research, Public and Professional Education Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 23, 2020 |
| Last Updated Date: | Feb 02, 2023 |
| Original Closing Date for Applications: | Jan 05, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Feb 05, 2023 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 07, 2023 |
| Estimated Total Program Funding: | $31,200,000 |
| Award Ceiling: | $1,040,000 |
| Award Floor: | $520,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Special district governments Small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The purpose of this NOFO is to: a) implement evidence-based provider and patient education and support tools in clinical settings to increase screening for PrEP indications, PrEP counseling, PrEP initiation, and PrEP adherence and persistence by MSM and b) to understand PrEP use and reasons for selection of a PrEP formulation and switching patterns associated with the use of daily, 2-1-1, and injectable PrEP. Implementation science methods will be used to evaluate the effectiveness of the provider education module and support tools. The recipient will also collect data to describe real-world PrEP use among MSM in an era of multiple PrEP options. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson
fzp0@cdc.gov Email:fzp0@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Revised closing date. | Feb 02, 2023 | |
| Oct 23, 2020 | ||
| Jul 23, 2020 | ||
| Jul 23, 2020 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-21-003 |
| Funding Opportunity Title: | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 93.941 — HIV Demonstration, Research, Public and Professional Education Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 23, 2020 |
| Last Updated Date: | Feb 02, 2023 |
| Original Closing Date for Applications: | Jan 05, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Feb 05, 2023 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 07, 2023 |
| Estimated Total Program Funding: | $31,200,000 |
| Award Ceiling: | $1,040,000 |
| Award Floor: | $520,000 |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Special district governments Small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The purpose of this NOFO is to: a) implement evidence-based provider and patient education and support tools in clinical settings to increase screening for PrEP indications, PrEP counseling, PrEP initiation, and PrEP adherence and persistence by MSM and b) to understand PrEP use and reasons for selection of a PrEP formulation and switching patterns associated with the use of daily, 2-1-1, and injectable PrEP. Implementation science methods will be used to evaluate the effectiveness of the provider education module and support tools. The recipient will also collect data to describe real-world PrEP use among MSM in an era of multiple PrEP options. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson
fzp0@cdc.gov Email:fzp0@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-21-003 |
| Funding Opportunity Title: | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 6 |
| Assistance Listings: | 93.941 — HIV Demonstration, Research, Public and Professional Education Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 23, 2020 |
| Last Updated Date: | Oct 23, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 05, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 04, 2021 |
| Estimated Total Program Funding: | $31,200,000 |
| Award Ceiling: | $1,040,000 |
| Award Floor: | $520,000 |
Eligibility
| Eligible Applicants: | Independent school districts State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this NOFO is to: a) implement evidence-based provider and patient education and support tools in clinical settings to increase screening for PrEP indications, PrEP counseling, PrEP initiation, and PrEP adherence and persistence by MSM and b) to understand PrEP use and reasons for selection of a PrEP formulation and switching patterns associated with the use of daily, 2-1-1, and injectable PrEP. Implementation science methods will be used to evaluate the effectiveness of the provider education module and support tools. The recipient will also collect data to describe real-world PrEP use among MSM in an era of multiple PrEP options. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Jocelyn Patterson
fzp0@cdc.gov Email:fzp0@cdc.gov |
DISPLAYING: Forecast 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-21-003 |
| Funding Opportunity Title: | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.941 — HIV Demonstration, Research, Public and Professional Education Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 2 |
| Posted Date: | Jul 23, 2020 |
| Last Updated Date: | Oct 23, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | – |
| Estimated Total Program Funding: | $5,200,000 |
| Award Ceiling: | $1,040,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Independent school districts State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to conduct implementation research to understand the selection, adherence, persistence, and switching patterns associated with the use of FDA approved PrEP formulations by men who have sex with men (MSM). Two oral medications have been approved by the FDA as PrEP medications for MSM. Both are recommended for daily use, and one is also recommended for 2-1-1 use before and after sex rather than daily. An injectable long-acting PrEP medication that is administered every 2 months is expected to become available in 2022. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:fzp0@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-PS-21-003 |
| Funding Opportunity Title: | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.943 — Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Jul 23, 2020 |
| Last Updated Date: | Jul 23, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | – |
| Estimated Total Program Funding: | $5,200,000 |
| Award Ceiling: | $1,040,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Independent school districts State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses City or township governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to conduct implementation research to understand the selection, adherence, persistence, and switching patterns associated with the use of FDA approved PrEP formulations by men who have sex with men (MSM). Two oral medications have been approved by the FDA as PrEP medications for MSM. Both are recommended for daily use, and one is also recommended for 2-1-1 use before and after sex rather than daily. An injectable long-acting PrEP medication that is administered every 2 months is expected to become available in 2022. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:fzp0@cdc.gov |
Related Documents
Folder 328319 Full Announcement-FULL_ANNOUNCEMENT -> RFA-PS-21-003.pdf
Packages
| Agency Contact Information: | Jocelyn Patterson fzp0@cdc.gov Email: fzp0@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.941 | RFA-PS-21-003 | PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices | PKG00263879 | Oct 23, 2020 | Jan 05, 2021 | View |
Package 1
Mandatory forms
328319 RR_SF424_2_0-2.0.pdf
328319 PHS398_CoverPageSupplement_5_0-5.0.pdf
328319 RR_OtherProjectInfo_1_4-1.4.pdf
328319 RR_Budget_1_4-1.4.pdf
328319 PHS398_ResearchPlan_4_0-4.0.pdf
328319 RR_KeyPersonExpanded_2_0-2.0.pdf
328319 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
328319 PerformanceSite_2_0-2.0.pdf
Optional forms
328319 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
